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Abstract	
  In a recent article (Gudlur et al., (2012) PLOS ONE, 7 (9) e45374) we described the special 
properties of a mixed branched peptide assembly in which equimolar bis(FLIVI)-K-KKKK and 
bis(FLIVIGSII)-K-KKKK self-associate to form bilayer delimited capsules capable of trapping 
solutes.  These poly-cationic vesicle-like capsules are readily taken up by epithelial cells in 
culture, escape or evade the endocytic pathway, and accumulate in the peri-nuclear region where 
they persist without any apparent degradation. In this report we examine the lipid-like properties 
of this system including initial assembly; solute encapsulation and washing; fusion and resizing 
by membrane extrusion through polycarbonate filters with defined pore sizes. The resized 
peptide capsules have uniform diameters in nm size ranges.  Once resized, the capsules can be 
maintained at the new size by storing them at 4° C.  Having the ability to prepare stable uniform 
nano-scale capsules of desired sizes makes them potentially attractive as biocompatible delivery 
vehicles for various solutes/drugs. 	
Introduction	
 
There is a need for new safe drug 
delivery vehicles that can better 
target specific tissues or organs and 
minimize off-target accumulation1. 
In Gudlur et al.2, we described, for 
the first time, a drug delivery system 
in which two peptides of different lengths; and designed to mimic diacyl glycerols (Fig. 1) form 
water filled vesicles.  In that paper we referred to these constructs as vesicles. Owing to the 
Figure 1. Branched Bilayer Forming Sequences 
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Figure 2. Scanning Transmission Electron
Micrograph (STEM) Hg-Labeled
Peptides 24 hr after mixing. Capsules were
prepared with 30% Me-Hg label in both
peptides at 0.1 mM. The images were
captured using annular dark field mode and
then inverted to produce the final image. 
heuristic association of lipids with vesicles; we have introduced the term ‘capsule’ in an effort to 
negate the confusion between our peptidic nano-spheres and traditional lipid vesicles.  
 
The branch point lysine orients the two peptide segments at a 90˚ angle, similar to the geometry 
of diacyl phospholipids. The bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-KKKK peptides 
together self-assemble with beta-like secondary structure to form a new class of capsules that are 
readily taken up by cells in culture while retaining trapped solutes.  Since neither peptide alone 
forms stable capsules, we hypothesized that two 
sizes are required to accommodate the curvature of 
assembled capsules.  The fact that they undergo 
self-assembly gives us the ability to modify 
individual peptides with various ligands or markers 
that can then be incorporated into the aggregate.  In 
the first paper we adducted the C-terminal lysine 
with fluorescent dyes and in another case included 
a cysteine residue at the C-terminus that was used 
to attach methyl mercury2.  The labeled peptides 
are usually incorporated at 30 mole percent with 
unlabeled peptides, without affecting assembly or 
cellular uptake.  The peptide capsules were also tested for thermal stability using Differential 
Scanning Calorimetry up to 95˚C and were found to maintain their structural and functional 
integrity at all studied temperatures.  In this study we report on the phospholipid vesicle-like 
characteristics of our assemblies.  The peptides are mixed and dried as monomers. Within 
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minutes of adding water to the dried peptides, fibrils form, which soon coalesce into 20 nm 
capsules.  It is during this phase that solutes become entrapped. Thereafter, the capsules begin 
fusing, and by 24 h appear as much larger structures (up to 1 μm, with most having diameters of 
50-200 nm) (see Fig. 2).  We were able to follow the fusion process by observing the dilution of 
a self-quenching fluorescent dye.  Since cell and tissue uptake is size dependent, we also 
examined the effects of extruding the larger capsules through membranes with various pore 
sizes. Dropping the temperature to 4° C suspends the fusion process allowing for storage of the 
uniform sized material. These studies together provide further evidence supporting the 
hypothesis that these branched sequences self-assemble into bilayers and form capsules in an 
aqueous environment.   
Materials	and	Methods	
 
Peptide Synthesis 
 Peptides were synthesized by solid phase peptide chemistry on 4-(2,4-Dimethoxyphenyl-Fmoc-
aminomethyl) phenoxyacetyl-norleucyl-cross-Linked Ethoxylate Acrylate Resin3  (Peptides 
International Inc; Louisville, Kentucky) on a 0.1 mmol scale using Fmoc (N-(9-fluorenyl) 
methoxycarbonyl)/tert-butyl chemistry on an ABI Model 431 peptide synthesizer (Applied 
Biosystems; Foster City, CA). The Fmoc amino acids were obtained from Anaspec, Inc 
(Fremont, CA). The branch point was introduced by incorporating Nα,ε di-Fmoc-L-Lysine in the 
fifth position from the C-terminus. De-protection of this moiety leads to the generation of two 
reactive amino sites that subsequently and simultaneous generate the bifurcated peptide branch 
point. This enables the addition of the hydrophobic tail segments FLIVI and FLIVIGSII to the 
common hydrophilic oligo-Lysine segment by the stepwise addition of Fmoc amino acids4.  The 
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N-terminal ends of the peptide were acetylated on the resin using Acetic Anhydride / N, N-
Diisopropylethylamine / 1-Hydroxybenzotriazole prior to cleavage. The peptide was cleaved 
from the resin using TFA/water (98:2, v/v) for 90 min at RT to generate C-terminal 
carboxamide. The peptide product was washed 3x with diethyl ether and re-dissolved in water 
prior to lyophilization.  The water used throughout this study is deionized, reverse osmosis 
treated and then distilled.  The RP-HPLC purified peptides were dried in vacuo and characterized 
on a Bruker Ultraflex III matrix-assisted laser desorption ionization time of flight mass 
spectrometer (MALDI TOF/TOF) (Bruker Daltonics, Billerica, MA) using 2,5-dihydroxybenzoic 
acid matrix (Sigma-Aldrich Corp., St. Louis, MO). The dried peptides were stored at room 
temperature.   
 
Peptide Modifications (Me-Hg-Cys) 
 The synthesis of the cysteine modified peptides were effected  on a 0.1mmol scale with standard 
Fmoc(N-(9-fluorenyl)methoxycarbonyl)/tert-butyl chemistry on CLEAR-Amide Resin (Peptides 
International Inc; Louisville, Kentucky) by means of N-α-Fmoc-S-p-methoxytrityl-L–cysteine 
(Anaspec, Inc; Fremont, CA) coupled to the resin at C-terminus. The remainder of the synthesis, 
cleavage, post cleavage processing and characterization was performed as previously described, 
to generate bis(FLIVI)-K-KKKK-C-CONH2 and bis(FLIVIGSII)-K-KKKK-C-CONH2 
respectively2. Both cysteine adducted peptides were solubilized in water and reacted with 1 
equivalent of Methylmercury(II) iodide (Sigma-Aldrich Corp., St. Louis, MO) at pH 9.8 for 6 h 
at RT5, 6. The resulting solution was reduced in vacuo and subsequently lyophilized to generate 
the desired product. The percent methyl mercury incorporated was determined by measuring the 
concentration of free cysteine remaining after the coupling reaction. Unlabeled peptides of equal 
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concentration served as the control.  Samples were treated with 4 mg/mL 5, 5’-Dithiobis-(2-
nitrobenzoic acid) (Sigma-Aldrich Corp., St. Louis, MO) in pH 8.2, 0.1 M phosphate buffer. The 
fully reacted sample absorbance values were measured at 412 nm on a CARY 50 Bio UV/Vis 
spectrophotometer (Varian Inc., Palo Alto, CA) using a 0.3 cm path length quartz cuvette (Starna 
Cells Inc., Atascadero, CA)7. The concentrations of the peptides were calculated using the molar 
extinction coefficient (ε) of phenylalanine residues (two per sequence) at 257.5 nm (195 cm-1 M-
1)8, 9.  
 
Capsule Formation and Encapsulation 
 The bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-KKKK peptides were dissolved individually 
in neat 2,2,2-Trifluoroethanol. In this solvent the peptides are helical and monomeric thereby 
ensuring complete mixing when combined. Concentrations were determined as diluted samples 
in water using the absorbance of phenylalanine as previously described. The bis(FLIVI)-K-
KKKK and bis(FLIVIGSII)-K-KKKK peptide samples were mixed in equimolar ratios to 
generate a final concentration of 0.1 mM, then dried in vacuo. The dried peptide samples were 
then hydrated to form capsules of desired concentration by the drop-wise addition of water. 
 
S/TEM Sample Preparation 
The 30% Me-Hg capsules were prepared in a manner similar to that previously detailed, by co-
dissolving 0.7 mole equivalents of bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-KKKK with 0.3 
mole equivalents of their respective cysteine containing Me-Hg labeled variants  in water, to a 
final concentration containing 0.1 mM  each of bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-
KKKK. The dried peptide mixture was hydrated and allowed to stand for the indicted time 
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intervals. Carbon Type A (15-25 nm) on 300 mesh support film grids with removable Formvar 
(Ted Pella Inc., Redding, CA) were immersed in chloroform to strip off the Formvar. These were 
subsequently negatively (hydrophilic) glow discharged10  at 5 mA for 20 s using a EMS 150 ES 
Turbo-Pumped Sputter Coater/Carbon Coater (Electron Microscopy Sciences, Hatfield, PA) - the 
carbon end of the grids being exposed to the plasma discharge making the carbon film 
hydrophilic and negatively charged, thus allowing easy spreading of aqueous suspensions. 
Capsule sample solutions (6 μL) were spotted on to grids and allowed to stand for 5 min, after 
which, excess solution was wicked off the grid with a Kimwipe™ tissue (Kimberly-Clark 
Worldwide Inc., Roswell, GA) and allowed to air dry before loading it into the FEI Tecnai 
F20XT Field Emission Transmission Electron Microscope (FEI North America,  Hillsboro, 
Oregon) with a 0.18 nm STEM HAADF resolution and a 150X – 2306 x 106 X range of 
magnification11. Scanning transmission electron microscopy was carried out in the annular dark 
field mode with a single tilt of 17°.   
 
Capsule Assembly Time Course Experiment 
 For the purposes of the time course experiment, 30% Me-Hg labeled 0.1mM, bis(FLIVIGSII)-
K-KKKK:bis(FLIVI)-K-KKKK  peptide capsules were prepared as before and spotted on 
negative glow discharged TEM grids at 0, 5, 25, 55 and 115 min post hydration to account for 
different time points (5,10, 30, 60 and 120 min respectively) during the process of assembly and 
fusion. For the purposes of the ‘0’ min time point; separate 2.5 μL 0.1mM bis(FLIVIGSII)-K-
KKKK and 2.5 μL 0.1 mM bis(FLIVI)-K-KKKK peptide samples were co-spotted on to the grid 
immediately upon hydration. After letting the sample stand on the grid for 5 min, the excess 
solution was wicked off, and the sample stained with 5 μL of an aqueous solution of 2% multi-
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isotope Uranyl Acetate (Uranium bis(acetato-o)dioxo-dihydrate). This was then allowed to stand 
for 5 min, after which the excess stain was wicked off and the sample allowed to air dry before 
studying it under a FEI Tecnai F20XT Field Emission Transmission Electron Microscope in the 
previously specified manner.   
 
Coarse-grained Modeling 
 A modified MARTINI force field2, 12-14 was used to describe the peptide and water molecules. 
The peptide backbone was represented by particle types for β secondary structure in the 
hydrophobic segments, and coil particle types for the poly-lysine C-termini.  The thickness of the 
bilayer membrane and the average area of each peptide were calculated by performing 100 ns 
molecular dynamics (MD) simulations of pure model bilayers2.  In order for the bilayer to 
maintain the capsule curvature restriction, the outside leaflet requires a greater amount of the 
longer peptide (2:1= bis(FLIVIGSII)-K-KKKK:bis(FLIVI) -K-KKKK) than the inside leaflet 
(1:2 = bis(FLIVIGSII)-K-KKKK:bis(FLIVI)-K-KKKK ).  This ratio was based on preliminary 
results obtained using a titration assay that measured the solvent exposed thiols of added C-
terminal cysteines in the assembled capsules (data not shown).  To avoid overlap of peptides, the 
initial diameter (~28 nm) of the capsule is built larger than the experimentally observed 20nm. 
After 200 steps of energy minimization, a total of ~2 ns equilibrium simulations were carried out 
at 298K by incorporating several steps, in which harmonic potentials with gradually increasing 
strength was imposed on the peptides. All simulations were performed in CHARMM14, 15 on the 
Beocat Research Cluster at Kansas State University. VMD16 was used for preparation of the 
snapshots presented in this work.  
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Eosin Self-Quenching Curve 
 The fluorescence self-quenching of eosin was recorded by exciting 0, 10, 20, 40, 80, 90, 100, 
125, 150, 175, 200, 400, 600, 800, 1000, 1500 and 2126 μM aqueous concentrations of eosin Y 
(Sigma-Aldrich Corp., St. Louis, MO) at 490 nm and scanning for observed emissions from 495-
800 nm with a CARY Eclipse Fluorescence spectrophotometer (Varian Inc., Palo Alto, CA) 
(Scan rate: 600 nm/min; PMT detector voltage: 600 V; Excitation slit: 5 nm; Emission slit: 5 nm) 
using a 0.3 cm path length quartz cuvette. The resulting data was plotted as change in 
fluorescence intensity as well as change in λmax as a function of increasing eosin concentration. 
Fluorescence intensity was seen to increase with eosin Y concentration until about 100 μM after 
which the trend was reversed, and the intensity of fluorescence proceeded to decrease such that 
the fluorescence intensity of 1.13 mM eosin Y solution was lower than that of a 10 μM solution 
of the same. A consistent red shift of λmax towards higher wavelengths was witnessed as a 
function of increasing concentrations of eosin Y – all consistent with the phenomenon of 
fluorescence self-quenching17.      
 
Salt Wash Study 
The bis(FLIVIGSII)-K-KKKK:bis(FLIVI)-K-KKKK  peptide capsules (1.0 mM) were prepared 
using the protocol described earlier. One hour post hydration, the capsule containing solution 
was centrifuged at 14,000 x g in Amicon ultra- 0.5 mL, 30K molecular weight cut-off (MWCO) 
centrifugal units with regenerated cellulose filters (Millipore, Billerica, MA) using a Thermo 
Electron Legend 14 personal micro-centrifuge (Thermo Fisher Scientific Inc., Waltham, MA). At 
the conclusion of the spin, the removable-filter unit was inverted and placed in a fresh tube and 
spun at 2000 x g for 5 min to recover the remaining volume containing the capsules. The filtered 
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preformed capsules were then incubated a 2.13 mM aqueous eosin Y solution for 30 min to coat 
the exterior surface.  The capsule-eosin solution was filtered as describe above to remove the 
excess eosin.  This solution was used as a control and its fluorescence measured by excitation at 
490 nm and scanning for observed emissions from 495-800 nm with a CARY Eclipse 
Fluorescence spectrophotometer as previously described. The samples were split into two 
aliquots – the first aliquot was washed with water prior to centrifugal MWCO filtration and the 
other with an equal volume of 200 mM Sodium Trifluoroacetate (Na-TFA, Sigma-Aldrich Corp., 
St. Louis, MO) - and simultaneously subjected to the MWCO centrifugation process along with 
isolation and re-solvation of the capsule containing solution. The samples were rescanned with 
the spectrometer.  Subsequently both sample were washed and centrifuged with just water 
multiple times samples and measured for eosin fluorescence after each centrifugal cycle. A cycle 
by cycle comparison between water washed capsules versus Na-TFA salt-water washed capsules 
demonstrated a significant decrease in the eosin fluorescence signal.  
 
Capsule Fusion Study 
 1.0 mM and 20.0 mM dried samples of bis(FLIVIGSII)-K-KKKK:bis(FLIVI)-K-KKKK  
peptide capsules were made in a manner analogous to the one previously described. Both these 
samples were simultaneously solvated; the 1 mM sample with aqueous 2.13 mM eosin Y and the 
20.0 mM sample with water, and then allowed to stand for 30 min. All samples were subjected to 
three 30 kDa MWCO centrifugation process cycles starting with a 5 min incubation with 200 
mM Na-TFA salt, and then spin filtered. For the second and third centrifugation cycles, the eosin 
encapsulating capsules were washed with water prior to centrifugation. At the end, both the 1.0 
mM and 20.0 mM capsules were suspended in water; then immediately mixed in equal volumes; 
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an aliquot of which was stored at 4˚C and the other placed in a 0.3 cm quartz cuvette and 
scanned for observed emission from 495-800 nm for 4 h with a scan every 5 min, upon excitation 
at 490 nm, with a CARY Eclipse Fluorescence spectrophotometer (Scan rate: 600 nm/min; PMT 
detector voltage: 800 V; Excitation slit: 5 nm; Emission slit: 5 nm). The 4˚C aliquot was scanned 
for change in fluorescence intensity at 6 h and 24 h intervals post mixing. The resulting data was 
plotted as change in intensity and change in λmax as a function of capsule fusion over time.  
 
Resizing the Capsules 
 A 0.1 mM solution of bis(FLIVIGSII)-K-KKKK:bis(FLIVI)-K-KKKK  peptide capsules with  
30% Me-Hg label was prepared in a manner as described previously and allowed to stand for 24 
h. A 6 µL aliquot was then loaded on a negatively glow discharged TEM grid, allowed to dry for 
5 min, with the excess solution wicked off and then air dried as previously described. The 24 h 
capsule solution was divided into two parts and then individually loaded in gas-tight syringes and 
extruded respectively through 0.1 µm and 0.03 µm 19 mm Whatman® Nuclepore™ Track-
Etched Polycarbonate Membranes using the Avanti® Mini-Extruder (Avanti Polar Lipids, Inc., 
Alabaster, AL); with at least 40 passes through the membrane per sample. The extruded samples 
were immediately spotted on negatively glow discharged TEM grids as with the 24 h sample and 
observed using a FEI Tecnai F20XT Field Emission Transmission Electron Microscope as 
before.  
 
Beta Amyloid Test 
 Due to the speed at which these peptides adopt beta-structure in water we tested the sequences 
to see if they were amyloids using the Thioflavin T assay13. In the presence of amyloid proteins 
 12
the fluorescence excitation and emission spectra of the dye are right shifted and enhanced 
emission at the new wavelength. 
  
Results	and	Discussion	
 
For this system to find utility as a drug delivery vehicle, there are numerous parameters requiring 
definition and control. These issues include — understanding capsule formation, controlling their 
size and tuning their stability.  The work presented here addresses the first two of these 
properties.  As shown in Fig. 2, at 24 h post hydration of the peptide mixture, we always observe 
a heterogeneous population of capsules. Preparing a defined and uniform size for these nano-
capsules can be highly useful since size is known to play a key role in where these materials 
segregate when used in vivo19-22.  Studies were performed to track capsule formation by 
following the time course for the appearance of the smallest observable capsules. Knowing this 
size provides guidance regarding the size of molecules capable of being entrapped.  Even though 
larger capsules ultimately form due to fusion, this initial size likely limits the size of the trapped 
solutes added during the initial hydration step.   
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Figure 3. Time course of capsule formation. S/TEM images of Hg-Labeled peptides taken at the
indicated times. Capsules contain 30% Me-Hg label in both the bis(FLIVI) and bis(FLIVIGSII)
peptides at 0.1 mM. The images were captured using annular dark field mode and then inverted to
produce the final image.  The scale bars at the bottom of the micrographs, in nm, are 200, 500, 200,
100, 200, and 500, for the 0, 5, 10, 30, 60 and 120 min time points, respectively.  
 
To begin, the four peptides— bis(FLIVI)-K-KKKK,  bis(FLIVIGSII)-K-KKKK, bis(FLIVI)-K-
KKKK-C-Hg-Me and bis(FLIVIGSII)-K-KKKK-C-Hg-Me are dissolved in 100% 
trifluoroethanol (TFE).  A ratio of 1:1 is set for all of the FLIVI and FLIVIGSII peptides. The 
methyl mercury peptides are present at a 30 mole percent and provide an electron dense heavy 
metal for visualizing the structures in S/TEM. In the electron beam, the irradiated Hg emits an X-
ray at a specific energy that can be detected and is visualized as a white glow in the S/TEM 
images.  In TFE, the peptides adopt a helical conformation, indicating a monomeric state where 
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they can mix completely.  When the solvent is removed in vacuo, the helical conformation is 
preserved as judged by the FTIR wave number for the Amide I band at 1650 cm-1 (data not 
shown).  Water is added to the dry material and mixed.  In water, the peptides begin to adopt a 
beta (extended) conformation and start assembling.  Aliquots were removed at the indicated 
times and dried on copper grids for imaging. Representative images at various time points are 
shown in Fig 3.  At t = 0, the peptides (glowing elements) appear as amorphous structures. 
However by 5 min, the peptides appear as long micron length nano fibrils that occur in clusters. 
Incubation of the nano fibrils with Thioflavin T did not result in any spectral shift, suggesting 
that an absence of amyloid structure in these fibrils23.  The fibril structures appear to be transient 
and quickly break down by 10 min, when the first capsules also start to appear.  Small and 
relatively uniform capsules of ~20 nm in diameter begin to accumulate by 30 min.  By 60 min, 
the small capsules begin to associate and form what appears to be, ‘spheres of spheres’.  The 
associations lead to spheres with different diameters as judged by the dark centers associated 
with the alignment of the 20 nm capsules. By 120 min the small capsules are no longer visible 
and appear to have all fused to make well-defined capsules of the sizes ranging from 100 nm to 
greater than 500 nm. These results illustrate the dynamic nature of the self-assembly process of 
the capsules.  
 
Based on the observation that 20 nm-sized capsules are the first to appear, we built a similarly 
sized capsule in silico using coarse-grained modeling to assess whether the peptide could be 
assembled into a bilayer that formed a stable capsule structure, and to illustrate a plausible three 
dimensional structure of the same.  The system was modeled using a modified version of the 
MARTINI coarse-grained (CG) force field2, 12, 13, 24 that was implemented in CHARMM14, 15. 
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Figure 4. Snapshots of initial and equilibrated structures of capsule coarse-grained model.
The C-terminus group is represented by a yellow sphere; outside peptides are shown as light grey
lines, with inside shown as cyan lines. The outside diameter of capsule is ~22nm 
The model capsule, shown in Fig. 4 left panel, contains a total of 1680 peptides, of which 1080 
and 600 peptides are on the outside and the inside leaflet, respectively. To overcome strain due to 
curvature, the outer leaflet contains 66.7% of the larger peptide while the inner leaflet contains 
only 33.3%.  After energy minimization and equilibration simulation, the capsule slightly 
contracted but well retained the overall structure.  The thickness of the outside leaflet is 
somewhat longer than that of the inside leaflet, due to higher ratio of the longer peptide. The 
inside volume of the capsule is about 760 nm3. The cross section of capsule (Fig. 4, right panel) 
shows that the two peptide leaflets have minimal inter-digitation, which is consistent with earlier 
IR results showing parallel beta-sheets2.  Inter-digitated strands would result in anti-parallel IR 
signatures.    
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As shown in Fig. 2 the capsules continually grow in size at room temperature and reach sizes in 
excess of a micron by 24 h.  To further establish that the growth is through direct fusion of small 
capsules, we measured the dilution of the self-quenching fluorescent dye eosin Y (2 mM) as a 
function of the loaded capsules fusing with a large excess of capsules containing just water. The 
surface of the capsules is highly cationic due to the presence of all the lysine residues and it 
adsorbs anionic compounds such as 5,6-Carboxyfluorescien in a saturable manner2.  Eosin Y is 
also anionic at neutral pH and can interact strongly with the outer surface of the capsules. The 
following protocol was developed to displace any surface-bound anionic molecules without 
compromising the integrity of the capsules or releasing their contents.  This protocol involves 
first washing the eosin Y loaded capsules with 200 mM Na-TFA at neutral pH, followed by two 
water washes.  The TFA- salt is a strong counter ion and easily displaces most of the dye in the 
first wash.  Water alone was also effective but required 5 washes to reach the 1% residual bound 
level.  Each wash takes additional time that, in turn, affects the size of the capsules as shown in 
the next set of experiments.  Use of the strong counter ion will also allow us to wash capsules 
free of negatively charged endotoxin (LPS), which can elicit innate immune responses in vivo. 
Eosin bound to the outer surface of preformed capsules shows an emission maximum at 535 nm, 
which corresponds to free eosin, indicating that its bound concentration is sufficiently low to 
prevent self-quenching.  After filtering the capsules containing 30% Me-Hg with the 0.22 μ 
polycarbonate filter and the previously described washing steps, a sample was removed for 
imaging by TEM, with a representative image shown in Fig. 5.  Most of the capsules are in the 
20-30 nm in size with several beginning to associate to form larger structures.  
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Being able to wash the surface clean of the anionic eosin Y allows us to assess the behavior of 
encapsulated material.  At 2.0 mM the self-
quenching dye has a λmax of 522 nm with an 
intensity just 22% of its maximum unquenched 
concentration, which has a red shifted λmax of 
550 nm. By mixing a small percentage of the 
salt/water washed eosin filled capsules with an 
excess of water filled capsules (1:20), the initial 
fusions lead to a rapid dilution of the dye.  As 
shown in Fig. 6A fluorescence intensity 
increases with a concomitant red shift at the 
earliest times. The fluorescence intensity 
increases as a consequence of the decreased self-quenching associated with each fusion event.  
The reaction was allowed to proceed for 235 min. At the end of the reaction the sample was salt 
washed and passed through a 30 kDa filter to measure any released dye.  No significant 
fluorescence was observed, indicating that the capsules remained intact throughout the 
experiment. Another control with all eosin-loaded capsules and no water capsules showed no 
increase in fluorescence over the same time frame. Fig. 6B is a derivative plot that shows the 
percent fluorescence increase at a given time point relative to the maximal fluorescence intensity 
observed. Because of the red shift that occurs during this process, the plotted intensity values 
were taken at the individual λmax values for each time point.  An apparent equilibrium is reached 
around 3 h.  This endpoint represents the time where all the capsules have attained equivalent 
Figure 5. TEM image of Me-Hg labeled
washed capsules just prior to fusion
experiment. 
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Figure 6. Capsule Fusion Study. Salt washed eosin Y trapped capsules were mixed with water 
filled capsules in the ratio of 1:20 at RT. A) Five min fluorescence scans of eosin encapsulated 
vesicles spectra were taken at 5 min intervals for 235 min. The inset shows spectrum of sample 
stored at 4° C for 6.5 h. The units shown are identical to those in panel A.  B)  Measured 
maximum eosin fluorescence intensity as a function of time during the fusion reaction.  The t = 0 
represents quenched value of salt washed eosin encapsulate in the capsules (2.0 mM). The data 
was fitted to a second order exponential with the error bars representing the SEM with n = 3.   
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entrapped concentrations.  Further fusions will continue as judged by EM studies; however there 
is no discernible change in the entrapped concentration of the larger structures.  
 
 The insert to Fig. 6A shows the fluorescence for an aliquot of the fusion sample stored for 6.5 h 
at 4° C. Note that the fluorescence spectrum is similar to that of the earliest time point in Fig. 
6A. The 6.5 h time window is well beyond the duration needed for the capsules to reach a 
maximum fluorescent intensity at room temperature. This result suggests that lowering the 
temperature to 4° C is sufficient to prevent the capsules from changing size through fusion; thus 
providing for a convenient means to control the capsule size. The cessation of fusion at the lower 
temperature is most likely a kinetic effect, with the process slowed down enough to afford better 
size control. The fusion experiment also provides further evidence that the capsules are hollow 
and water filled.  Given the amphiphilic nature of the peptides, the most reasonable explanation 
of how a water-filled capsule could form is that they behave like diacyl phospholipids and 
assemble into bilayers thereby creating a hydrophilic lined hollow space (see Fig. 4).  The 
 19
Figure 7. Filter Resizing Study. TEM images are shown for the A) 24 h control. B) 100 nm 
membrane extruded material and C) 30 nm membrane extruded material. All figures are displayed as 
inverse images. 
A. B. C. 
capsule’s propensity to fuse at room temperature tends to result in a heterogeneous population 
with a significant range of sizes on the order of microns. This property is undesirable for 
potential applications as drug delivery vehicles due to strict size dependent cellular uptake in 
vivo.  Liposomes made from diacyl phospholipids are easily resized to uniform diameters using 
membrane extrusion filters.  Given the behavioral similarities of the peptide capsules to lipid 
vesicles, applying membrane extrusion to resize the peptide capsules seems appropriate.  In the 
resizing experiment the Me-Hg labeled peptides were mixed and allowed to fuse for 24 h at RT.  
The size distribution observed is typical for a 24 h sample. At that point an aliquot of the peptide 
capsule solution was extruded back and forth numerous times through a 100 nm membrane filter 
followed by a final extrusion using a 30 nm membrane filter.  Immediately after repeated 
extrusions through each membrane, a small volume was spread on a TEM grid and dried. The 24 
hr sample (Fig. 7A) shows the larger peptide capsules normally seen at this time point.  The 100 
nm, extruded sample (Fig. 7B) shows a mixed population of heterogeneous capsules that range 
in size from 20 to 60 nm in diameter.  Few if any 100 nm capsules have ever been observed 
using this technique suggesting that this size is disfavored over smaller ones.  The 30 nm filter 
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extruded capsules (Fig. 7C) are observed as a relatively homogeneous population with most 
capsules ranging in diameter from 20-30 nm.  The 30 nm pore size is the smallest available 
through our vendor and attempting to go even smaller may not be feasible since our capsules 
assemble as 20 nm structures.  After extruding, if the capsules are allowed to sit for any 
appreciable time at RT they rapidly begin re-fusing (data not shown). In the absence of 
refrigeration, we envision using the samples immediately after the extrusion process to ensure 
size uniformity. Upon dilution in the blood stream or tissues, the likelihood of fusion is remote.  
This study clearly shows that regulating the size of the capsules is straightforward.  
Conclusion	
 
In this report we characterized several properties of peptide capsules that form through the self-
assembly of two branched peptides, bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-KKKK (Fig. 
1).  The assembly process is initiated with the formation of nano-fibrils that condense into 20 nm 
water filled spheres. It is during this phase that solutes can be encapsulated.  Washes with strong 
counter-ions followed by water washes remove any surface bound materials without disrupting 
the loaded capsules. Subsequently the nano capsules begin to associate to form spheres of 
spheres that ultimately fuse to form larger capsules.  The larger capsules continue to fuse and 
grow to more than micron diameter structures.  Fusion kinetics were followed by observing the 
dilution of the encapsulated self-quenching eosin Y dye, as dye labeled capsules combined with 
an excess of water containing capsules. The capsules are easily resized to form homogeneous 
populations in the 20-30 nm range by extruding them through polycarbonate filters with 
controlled pore sizes.  In addition, dropping the temperature to 4° C suspends the fusion process 
allowing the production of uniform and stable peptide capsules that could be used in vivo. 
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